|
|
||||||||
|
Interact CardioVasc Thorac Surg 2009;8:316-320. doi:10.1510/icvts.2008.193672 © 2009 European Association of Cardio-Thoracic Surgery
Video-assisted thoracic surgery lobectomy preserves more latissimus dorsi muscle than conventional surgery
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract |
|---|
|
|
|---|
Key Words: Video-assisted thoracic surgery; Posterolateral thoracotomy; Latissimus dorsi muscle; Quality of life
| 1. Introduction |
|---|
|
|
|---|
Postoperative atrophy of the latissimus dorsi muscle (LDM) after conventional posterolateral thoracotomy has been reported by a few authors [2, 3]. However, to our knowledge, there is no report that quantitatively analyzes the atrophic change of LDM postoperatively. In this study, we measured the cross-section of LDM by computed tomography (CT), so as to quantify the atrophy of LDM, which may be one of the indicators of invasiveness of the thoracic wall muscles.
| 2. Patients and methods |
|---|
|
|
|---|
The PLT consisted of an approximately 20-cm skin incision with a complete division of LDM. Serratus anterior muscle was preserved and the 5th rib was split to obtain an intrathoracic approach. In VATS, 3 or 4 access ports were inserted through 1
2 cm skin incisions in the side of the chest. Lobectomy was performed through these small incisions. One of these skin incisions was extended by 3–4 cm, and the lung lobe for resection was removed in a plastic bag without using a rib retractor. Patients in whom VATS was replaced intraoperatively with open thoracotomy were counted as open thoracotomy patients. Two patients whose incisions were extended to 8 cm and 10 cm, respectively, with the use of a small rib retractor were excluded from this study because they could be counted as thoracotomy patients.
In order to quantify the atrophy of the thoracic wall muscles after lobectomy, we measured the cross-section of LDM in preoperative and postoperative chest CTs of the patients with VATS and PLT. The preoperative CT was taken within three months of the surgery, and the postoperative CT was taken about one year after surgery. One patient with VATS and four with PLT were excluded from this study because their CTs did not meet the criteria above. Slice thickness and intervals were both set at 5 mm in all CT images. Window levels and widths were between 35 and 75 H.U., and between 250 and 350 H.U., respectively. The cross-section of the bilateral LDM was measured for each patient in both preoperative and postoperative CT. For the measurement of the cross-section of the LDM, the slice showing the lower tip of the ipsilateral scapula was chosen. The contour of the LDM on the selected CT image in JPEG format was drawn manually on the Microsoft Excel worksheet (Microsoft Corp., Redmond, WA, USA), and the area was calculated with a free macro program downloaded from the internet (lenaraf220) (http://www.vector.co.jp/download/file/win95/art/fh442375.html, Vector Japan Co, Ltd, Tokyo, Japan). Patient names, CT-scan dates and types of surgery were blinded, and the CT-scans were randomized. Measurements were made by two trained observers. The postoperative/preoperative ratio of the LDM cross-section was calculated to demonstrate atrophy of the LDM postoperatively.
Statistical analysis was performed using SAS version 9.1.3 (SAS Institute, Inc, Cary, NC, USA). The intraclass correlation coefficient of the preoperative LDM cross-section was calculated to assess the reliability of the measuring method performed by two observers. All continuous variables are expressed as mean±one standard deviation. Continuous data were analyzed with Student's t-test. Frequencies were compared using
2-tests. All reported probability values are two-tailed, and P values <0.05 were considered statistically significant.
| 3. Results |
|---|
|
|
|---|
Four patients in the PLT group who were pathological stage III were excluded from this study because they received adjuvant chemotherapy before the one-year follow-up. Fourteen patients in the VATS group and 24 patients in the PLT group were assessed. Patient characteristics are shown in Table 1. No recurrence of the NSCLC was seen during the one-year postoperative follow-up. One patient in the VATS group was considered to have adenocarcinoma, according to the intraoperative pathological diagnosis, but the diagnosis was altered postoperatively to atypical adenomatous hyperplasia.
|
|
|
|
| 4. Discussion |
|---|
|
|
|---|
Several studies have shown that postoperative morbidity and mortality of VATS lobectomy were as good as, or rather better than, those of conventional thoracotomy [4, 5]. The hilar and mediastinal lymph node dissections are controversial from the oncological viewpoint, but some recent reports indicate that the lymph node dissections through thoracoscopy can satisfactorily be done thoroughly [6, 7], probably because of evolution of the technique and more thorough training of surgeons. The long-term postoperative survival rate of patients with NSCLC undergoing VATS lobectomy has been reported to be equal to that of patients undergoing thoracotomy [5–7].
The postoperative QOL has been evaluated by respiratory functional reserve, shoulder movement, wound pain, duration of hospital stay, and biological markers such as c-reactive protein and interleukin-6 [4, 7–11]. The majority of issues favorably assisted the thoracoscopy, especially in the early postoperative period. In this study, we focused on postoperative atrophic change in the latissimus dorsi muscle as an indicator of the performance status of patients undergoing lung cancer surgery.
We used our own criteria, based on previous studies, and our own clinical experience, as indications for VATS lobectomy for NSCLC: age 75 years or more, severe systemic complications, or small Stage IA adenocarcinoma. Therefore, older patients and patients with more severe systemic complications were more likely to undergo VATS. From the analysis of the LDM on the non-surgical side, we have shown that this muscle tends in the elderly to be more atrophic than in younger patients after a lobectomy. We may therefore say that age is a major factor in postoperative atrophy of the chest wall muscles. In this study, the reduction of the size of the LDM on the non-surgical side after VATS was slightly greater than that after PLT. This could perhaps be explained by the larger number of patients with systemic complications and slightly higher age of the patients in the VATS group. Nonetheless, the atrophy of LDM on the surgical side was more severe after PLT. We may assume that VATS preserves more LDM than conventional thoracotomy.
Animal experiments and clinical studies have shown that denervation of the muscle may be the major cause of atrophy [12, 13]. There are several reports which suggest that VATS has a better prognosis for short-term postoperative pain than PLT [4, 7–9]. However, it is reported that there is no significant difference in long-term postoperative pain between VATS and PLT [9], which indicates that postoperative disuse due to pain is less likely to be the cause of the atrophy of LDM. On the other hand, scientific support is lacking, short-term postoperative pain may delay the rehabilitation of shoulder movement after PLT, which also may promote LDM atrophy.
A questionnaire survey by Li et al. in 2003 showed that there was no significant difference between PLT and VATS three months after surgery in terms of various activities of daily living (ADL) such as putting on clothing [10]. On the other hand, it is well known that the muscle strength and cross-section are usually correlated [14], and LDM strength reduction due to LDM atrophy is inevitable – but, of course, the muscle strength required in ADL is small, although not, for example, in more energetic shoulder and arm exercise. Further study is needed regarding the long-term prognosis for shoulder function.
Limitations of this study include the small patient number and the non-randomized, retrospective nature of the study. Although consecutive patients were evaluated in this study, we used our own criteria, stated above, when recommending VATS lobectomy as a treatment of choice. As a result, background of each group was different in some aspects. Another limitation of this study was that we could not show the clinical relevance of LDM atrophy to postoperative QOL. A prospective study with a larger number of patients is required to confirm the larger LDM atrophy and deterioration of QOL after conventional thoracotomy.
There were other limitations in the method of LDM measurement used in this study. From our experience, the LDM has a relatively large cross-section on a CT slice showing the inferior tip of the scapula, and this is why we chose this particular slice when measuring the cross-section of LDM. However, this measuring method involved several problems. First, elevation of the arms may induce a positional change of the inferior tip of the scapula or deformation of the LDM; and second, a relationship between dissection of the serratus anterior muscle (SAM) and a postoperative winged scapula has previously been suggested [15], and displacement of scapula may have changed the conditions of measurement, which may have skewed the result. In our institution, we almost always preserve SAM during PLT, and so the displacement was not a big issue in most of the cases in the present study, but was still seen in some.
| 5. Conclusions |
|---|
|
|
|---|
| Conference discussion |
|---|
|
|
|---|
Dr. Karasaki: As I said, one of the limitations of this study was that we couldn't show the clinical relevance. So we didn't perform the study regarding the muscle strengths or the respiratory function. So my answer is no.
Dr. Cassivi: Since you're bringing the patients back a year later for a CT-scan, you might want to do some strength testing just to see if there is any benefit or any difference afterwards.
Dr. Karasaki: That is the next study I'm thinking about.
Dr. Cassivi: Fair enough. The second question is a little bit unrelated to the nature of your study, but it's something that maybe you can enlighten us all on. Whenever we have cross-cultural exchanges like this where we see how surgery is done in one part of the world and another, it raises some questions. One of the reasons we do VATS is to get patients back to their community and back into the swing of things, so to speak. I understand that your length of stay after VATS is 14 days?
Dr. Karasaki: Yes. Actually, I was also surprised to see this number. In Japan the patients are staying in the hospital definitely longer than in the other countries and the government is now working on a shorter hospital stay. I was surprised to see this number because now the hospital length of stay is shorter than the number I showed.
Dr. C. Saldarriaga (Medellin, Colombia): I have a concern. Do you use low-dose radiation chest CT, and do you have an approval by your board in your hospital for this kind of investigation? I have a concern about the radiation from the CT for this investigation. By the way, I would like to invite you to use more muscle-sparing thoracotomies than dorsal section thoracotomies.
Dr. Karasaki: What you mean is if we used the same machine?
Dr. Saldarriaga: With the chest CT do you use low-dose radiation, like for screening? If you use the radiation from a conventional CT for this investigation, it is very dangerous.
Dr. Karasaki: I don't know the exact number, but the CT-scan conditions were all the same and the slice interval was 5 mm, and so I think it was the same conditions as screening.
Dr. J. Nakajima (Tokyo, Japan): I am a co-author of the paper.
Actually, we routinely follow-up the patients after surgery, performing the chest and the abdominal CT-scan every six months for two years to examine recurrence of the lung cancer. Data of this study were obtained from these CT images. Thus the patients have not undergone additional radiation exposure for this study.
Dr. L. Lang-Lazdunski (London, UK): I have two short questions. First, you said for your VATS lobectomy you make 3 or 4 1 cm to 2 cm incisions. I would be interested to know how you get your lobe out through a 1 cm to 2 cm incision.
Second, did you use the same analgesia in open and VATS patients? Did you use an epidural catheter or PCA or a paravertebral block? That could obviously influence your results. And in patients who had VATS, I suppose you didn't divide the latissimus dorsi pedicle.
Dr. Karasaki: The first question about the size of the incision, when retracting the resected lobe, we extend the incision to about 4 cm to 6 cm, on average.
Dr. Lang-Lazdunski: And the analgesia was the same in both groups?
Dr. Karasaki: In most of the cases we used an epidural besides the general anesthesia.
Dr. Lang-Lazdunski: For both groups?
Dr. Karasaki: Yes, for the postoperative pain.
Dr. N. Novoa (Salamanca, Spain): I would like to make a comment. I think that now we have sufficient knowledge to do surgery through very small incisions, and your work will help people to not use such huge thoracotomies as they previously were using. But my real comment goes to not only muscle-sparing thoracotomies, but also, do you think there is a necessity to do the whole procedure as a closed procedure, and before removing the lobe, you need to open one of the skin incisions a little bit? You can do the complete procedure through a 3 cm, 4 cm, 5 cm little incision without any difference and not doing difficult things through VATS, a completely closed procedure. It was just a comment.
| Acknowledgements |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |